ObsEva (NASDAQ:OBSV) Now Covered by StockNews.com

Posted by on Jan 3rd, 2025

StockNews.com began coverage on shares of ObsEva (NASDAQ:OBSV – Free Report) in a report released on Thursday. The firm issued a hold rating on the stock.

ObsEva Price Performance

The stock has a market capitalization of $7.94 million, a price-to-earnings ratio of -0.11 and a beta of 0.68. The company’s 50-day moving average is $0.01. ObsEva has a 12-month low of $0.08 and a 12-month high of $2.14.

ObsEva Company Profile

(Get Free Report)

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.

Read More

Receive News & Ratings for ObsEva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ObsEva and related companies with MarketBeat.com's FREE daily email newsletter.